NovMetaPharma Co., Ltd.

Patent Applications and Registrations

Patent applications and USPTO patent grants for NovMetaPharma Co., Ltd..The latest application filed is for "use of composition for preventing, ameliorating, or treating bone loss disorders, comprising cyclo-hispro (chp) and parathyroid hormone".

Company Profile

19.14.31

NovMetaPharma Co., Ltd. - Seoul N/A KR

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Composition for cell protection containing cyclo histidine-proline as active ingredient Grant 11,433,114 - Jung , et al. September 6, 2	2022-09-06
Method for the treatment of pancreatitis Grant 11,413,270 - Lee , et al. August 16, 2	2022-08-16
Use Of Composition For Preventing, Ameliorating, Or Treating Bone Loss Disorders, Comprising Cyclo-hispro (chp) And Parathyroid Hormone App 20220218793 - JUNG; Hoe Yune ; et al.	2022-07-14
Use Of Cyclo(his-pro) (chp) For Preventing, Ameliorating, Or Treating Fibrosis App 20220202897 - JUNG; Hoe Yune ; et al.	2022-06-30
Use Of Cyclo(his-pro) (chp) For Preventing, Alleviating Or Treating Peritoneal Fibrosis App 20220193179 - JUNG; Hoe Yune ; et al.	2022-06-23
Antithrombotic composition containing Polygonum cuspidatum sieb. et zucc. and Cinnamomum cassia blume Grant 11,273,196 - Kim , et al. March 15, 2	2022-03-15
Method For Treating Inflammatory Bowel Diseases App 20220054541 - JUNG; Hoe Yune	2022-02-24
Pharmaceutical Composition For Preventing Or Treating Obesity, Containing CYCLO(HIS-PRO) As Active Ingredient App 20210401880 - Lee; Heon Jong ; et al.	2021-12-30
Compositions And Methods For Treating Virus Infection App 20210393731 - JUNG; Hoe-Yune ; et al.	2021-12-23
Composition For Cell Protection Containing Cyclo Histidine-proline As Active Ingredient App 20210161998 - Jung; Hoe-Yune ; et al.	2021-06-03
Pharmacological Formulation Comprising Cyclo (HIS-PRO) As Effective Ingredient For Preventing Or Treating Diabetes Mellitus App 20210100872 - Lee; Heon Jong ; et al.	2021-04-08
Novel Polymorphic Forms Of Cyclo (-his-pro) App 20210061854 - OLMSTEAD; Kay ; et al.	2021-03-04
Composition for cell protection containing cyclo histidine-proline as active ingredient Grant 10,918,693 - Jung , et al. February 16, 2	2021-02-16
Pharmaceutical Composition For Preventing Or Treating Diabetes, Containing Zinc Salt, Cyclo-hispro And Antidiabetic Drug As Active Ingredients App 20200353034 - JUNG; Hoe Yune ; et al.	2020-11-12
Compositions And Methods For Treatment Of Atherosclerosis App 20200345728 - Song; Moon Ki ; et al.	2020-11-05
Composition Comprising Chp (cyclo-his Pro) For Preventing, Improving Or Treating Of Bone Loss Related Disease App 20200338156 - JUNG; Hoe Yune ; et al.	2020-10-29
Pharmaceutical composition comprising amodiaquine and anti-diabetes drug as effective ingredient for prevention or treatment of diabetes Grant 10,792,280 - Kim , et al. October 6, 2	2020-10-06
Antithrombotic Composition Containing Polygonum Cuspidatum Sieb. Et Zucc. And Cinnamomum Cassia Blume App 20200282000 - KIM; Hyo Jung ; et al.	2020-09-10
Polymorphic forms of Cyclo (-His-Pro) Grant 10,683,300 - Olmstead , et al.	2020-06-16
Novel Polymorphic Forms Of Cyclo (-his-pro) App 20200017509 - Olmstead; Kay ; et al.	2020-01-16
Composition For Cell Protection Containing Cyclo Histidine-proline As Active Ingredient App 20190290720 - Jung; Hoe-Yune ; et al.	2019-09-26
Pharmaceutical Composition Comprising Amodiaquine And Anti-diabetes Drug As Effective Ingredient For Prevention Or Treatment Of App 20190175583 - KIM; Kyong Tai ; et al.	2019-06-13
Composition for preventing, alleviating or treating metabolic diseases, containing amodiaquine as active ingredient Grant 10,004,727 - Kim , et al. June 26, 2	2018-06-26
Composition For Preventing, Alleviating Or Treating Metabolic Diseases, Containing Amodiaquine As Active Ingredient App 20180042917 - KIM; Kyong Tai ; et al.	2018-02-15

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.